Global Oral Solid Dosage Contract Manufacturing Market Report 2026–2035: Key Forecasts and Growth Areas
Uncover key drivers, emerging technologies, and competitive movements shaping the oral solid dosage contract manufacturing market from 2026–2035 with trusted insights from The Business Research Company
By how much is the Oral Solid Dosage Contract Manufacturing Market expected to grow between 2026 and 2030?
The oral solid dosage contract manufacturing market size has observed substantial expansion in recent years. It is anticipated to increase from $42.39 billion in 2025 to $45.59 billion in 2026, recording a compound annual growth rate (CAGR) of 7.6%. The expansion witnessed historically stems from various factors, including heightened impetus to lower in-house production expenditures, the increasing intricacy of oral solid dosage formulations, a rise in generic drug manufacturing volumes, restricted internal production capabilities within pharmaceutical companies, and a greater dependency on external Contract Manufacturing Organizations (CMOs).
The oral solid dosage contract manufacturing market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $59.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period is driven by several factors, including an escalating demand for scalable pharmaceutical manufacturing solutions, an expanding pipeline of oral solid dosage drugs, increased investment in advanced manufacturing technologies, the broadening scope of pharmaceutical outsourcing in developing markets, and a growing requirement for adaptable and swift production capacities. Key trends identified for this period encompass a rise in pharmaceutical companies outsourcing oral solid dosage manufacturing, a greater need for high-volume and cost-effective tablet and capsule production, the increasing adoption of modified and controlled release oral solid dosage forms, an enhanced emphasis on regulatory compliance and quality assurance within contract manufacturing, and a growing preference for comprehensive, end-to-end manufacturing and packaging services.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp
Which Drivers Are Influencing Market Acceleration In The Oral Solid Dosage Contract Manufacturing Market?
The growing demand for generic drugs is expected to propel the future growth of the oral solid dosage contract manufacturing market. Generic drugs are medications that are bioequivalent to brand-name drugs in dosage, strength, safety, performance, quality, and intended use. The increasing demand for generic drugs is attributed to patent expirations, efforts to contain costs, regulatory incentives, and expanding access to healthcare. Oral solid dosage contract manufacturing significantly aids in the production and distribution of generic drugs by leveraging the capabilities of contract manufacturers to enhance their operational efficiency, reduce costs, ensure high-quality production, and bring their products to market more swiftly and effectively. For instance, in 2025, according to the Food and Drug Administration, a US-based federal agency reported that, more than 35,000 generic drugs have been approved by FDA. 9 out of 10 prescriptions are filled with generic drugs. Further, in November of 2024, FDA published over 800 revised PSGs for immediate-release solid oral generic drug products. Therefore, the demand for generic drugs drives the growth of the oral solid dosage contract manufacturing market.
What Leading Segments Are Studied In The Oral Solid Dosage Contract Manufacturing Market?
The oral solid dosage contract manufacturing market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies
Subsegments:
1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules
3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders
4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules
5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules
Which Trends Are Influencing The Development Of The Oral Solid Dosage Contract Manufacturing Market?
Leading companies within the oral solid dosage contract manufacturing market are concentrating on developing innovative solutions, such as continuous manufacturing lines, to maintain their market position. A continuous manufacturing line describes a production facility or system that employs continuous manufacturing processes to produce pharmaceuticals or other goods. For example, in January 2023, WuXi STA, a pharmaceutical company based in China, unveiled its inaugural continuous manufacturing line for oral solid pharmaceutical products. This state-of-the-art facility signifies a substantial progression in pharmaceutical production, harnessing continuous manufacturing principles to improve the efficiency, quality, and flexibility of drug manufacturing processes. This enhanced agility streamlines production timelines and lessens downtime, ultimately accelerating the supply of crucial medications to patients.
Which Key Players Are Driving Competition In The Oral Solid Dosage Contract Manufacturing Market?
Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Oral Solid Dosage Contract Manufacturing Market?
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Oral Solid Dosage Contract Manufacturing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp
Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Oral Solid Dosage Pharmaceutical Formulation Market Report 2026
Fill Finish Pharmaceutical Contract Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
